<SEC-DOCUMENT>0001829126-25-001006.txt : 20250214
<SEC-HEADER>0001829126-25-001006.hdr.sgml : 20250214
<ACCEPTANCE-DATETIME>20250214165628
ACCESSION NUMBER:		0001829126-25-001006
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		<ITEMS>06b
FILED AS OF DATE:		20250214
DATE AS OF CHANGE:		20250214
EFFECTIVENESS DATE:		20250214

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-538389
		FILM NUMBER:		25630411

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0708</schemaVersion>

    <submissionType>D</submissionType>

    <testOrLive>LIVE</testOrLive>

    <primaryIssuer>
        <cik>0001130166</cik>
        <entityName>Cyclacel Pharmaceuticals, Inc.</entityName>
        <issuerAddress>
            <street1>200 CONNELL DRIVE, SUITE 1500</street1>
            <city>BERKELEY HEIGHTS</city>
            <stateOrCountry>NJ</stateOrCountry>
            <stateOrCountryDescription>NEW JERSEY</stateOrCountryDescription>
            <zipCode>07922</zipCode>
        </issuerAddress>
        <issuerPhoneNumber>908-517-7330</issuerPhoneNumber>
        <jurisdictionOfInc>DELAWARE</jurisdictionOfInc>
        <issuerPreviousNameList>
            <previousName>MolecuRx, Inc.</previousName>
            <previousName>CDR Therapeutics, Inc.</previousName>
            <previousName>Xcyte Therapies, Inc</previousName>
        </issuerPreviousNameList>
        <edgarPreviousNameList>
            <previousName>XCYTE THERAPIES INC</previousName>
        </edgarPreviousNameList>
        <entityType>Corporation</entityType>
        <yearOfInc>
            <overFiveYears>true</overFiveYears>
        </yearOfInc>
    </primaryIssuer>

    <relatedPersonsList>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>David</firstName>
                <lastName>Lazar</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Cyclacel Pharmaceuticals, Inc.</street1>
                <street2>200 Connell Drive, Suite 1500</street2>
                <city>Berkeley Heights</city>
                <stateOrCountry>NJ</stateOrCountry>
                <stateOrCountryDescription>NEW JERSEY</stateOrCountryDescription>
                <zipCode>07922</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>David</firstName>
                <lastName>Natan</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Cyclacel Pharmaceuticals, Inc.</street1>
                <street2>200 Connell Drive, Suite 1500</street2>
                <city>Berkeley Heights</city>
                <stateOrCountry>NJ</stateOrCountry>
                <stateOrCountryDescription>NEW JERSEY</stateOrCountryDescription>
                <zipCode>07922</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Avraham</firstName>
                <lastName>Ben-Tzvi</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Cyclacel Pharmaceuticals, Inc.</street1>
                <street2>200 Connell Drive, Suite 1500</street2>
                <city>Berkeley Heights</city>
                <stateOrCountry>NJ</stateOrCountry>
                <stateOrCountryDescription>NEW JERSEY</stateOrCountryDescription>
                <zipCode>07922</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Spiro</firstName>
                <lastName>Rombotis</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Cyclacel Pharmaceuticals, Inc.</street1>
                <street2>200 Connell Drive, Suite 1500</street2>
                <city>Berkeley Heights</city>
                <stateOrCountry>NJ</stateOrCountry>
                <stateOrCountryDescription>NEW JERSEY</stateOrCountryDescription>
                <zipCode>07922</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Paul</firstName>
                <lastName>McBarron</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Cyclacel Pharmaceuticals, Inc.</street1>
                <street2>200 Connell Drive, Suite 1500</street2>
                <city>Berkeley Heights</city>
                <stateOrCountry>NJ</stateOrCountry>
                <stateOrCountryDescription>NEW JERSEY</stateOrCountryDescription>
                <zipCode>07922</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Samuel</firstName>
                <lastName>Barker</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Cyclacel Pharmaceuticals, Inc.</street1>
                <street2>200 Connell Drive, Suite 1500</street2>
                <city>Berkeley Heights</city>
                <stateOrCountry>NJ</stateOrCountry>
                <stateOrCountryDescription>NEW JERSEY</stateOrCountryDescription>
                <zipCode>07922</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
        </relatedPersonInfo>
    </relatedPersonsList>

    <offeringData>
        <industryGroup>
            <industryGroupType>Biotechnology</industryGroupType>
        </industryGroup>
        <issuerSize>
            <revenueRange>Decline to Disclose</revenueRange>
        </issuerSize>
        <federalExemptionsExclusions>
            <item>06b</item>
        </federalExemptionsExclusions>
        <typeOfFiling>
            <newOrAmendment>
                <isAmendment>false</isAmendment>
            </newOrAmendment>
            <dateOfFirstSale>
                <value>2025-02-06</value>
            </dateOfFirstSale>
        </typeOfFiling>
        <durationOfOffering>
            <moreThanOneYear>false</moreThanOneYear>
        </durationOfOffering>
        <typesOfSecuritiesOffered>
            <isEquityType>true</isEquityType>
            <isOptionToAcquireType>true</isOptionToAcquireType>
            <isSecurityToBeAcquiredType>true</isSecurityToBeAcquiredType>
        </typesOfSecuritiesOffered>
        <businessCombinationTransaction>
            <isBusinessCombinationTransaction>false</isBusinessCombinationTransaction>
        </businessCombinationTransaction>
        <minimumInvestmentAccepted>0</minimumInvestmentAccepted>
        <salesCompensationList></salesCompensationList>
        <offeringSalesAmounts>
            <totalOfferingAmount>0</totalOfferingAmount>
            <totalAmountSold>0</totalAmountSold>
            <totalRemaining>0</totalRemaining>
            <clarificationOfResponse>*Total Offering Amount and Total Amount Sold relate to amounts issued pursuant to the Warrant Exchange Agreement with Armistice Capital Master Fund Ltd., as further disclosed in item1.01 of the Issuer's Current Report on Form 8-K filed on February 5,2025.</clarificationOfResponse>
        </offeringSalesAmounts>
        <investors>
            <hasNonAccreditedInvestors>false</hasNonAccreditedInvestors>
            <totalNumberAlreadyInvested>1</totalNumberAlreadyInvested>
        </investors>
        <salesCommissionsFindersFees>
            <salesCommissions>
                <dollarAmount>0</dollarAmount>
            </salesCommissions>
            <findersFees>
                <dollarAmount>0</dollarAmount>
            </findersFees>
            <clarificationOfResponse></clarificationOfResponse>
        </salesCommissionsFindersFees>
        <useOfProceeds>
            <grossProceedsUsed>
                <dollarAmount>0</dollarAmount>
            </grossProceedsUsed>
            <clarificationOfResponse></clarificationOfResponse>
        </useOfProceeds>
        <signatureBlock>
            <authorizedRepresentative>false</authorizedRepresentative>
            <signature>
                <issuerName>Cyclacel Pharmaceuticals, Inc.</issuerName>
                <signatureName>/s/ David Lazar</signatureName>
                <nameOfSigner>David Lazar</nameOfSigner>
                <signatureTitle>Interim Chief Executive Officer</signatureTitle>
                <signatureDate>2025-02-14</signatureDate>
            </signature>
        </signatureBlock>
    </offeringData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
